Taiwanese Journal of Obstetrics and Gynecology
Volume 48, Issue 4 , Pages 350-355, December 2009

Effect of Estrogen on the Activity and Growth of Human Osteoclasts In Vitro

  • Fang-Ping Chen

      Affiliations

    • Department of Obstetrics and Gynecology, National Taiwan Ocean University, Keelung, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Fang-Ping Chen, Department Of Obstetrics and Gynecology, Keelung Chang Gung Memorial Hospital, 222, Mai-Chin Road, Keelung, Taiwan
    • ,
  • Kun-Chuang Wang

      Affiliations

    • Department Orthopedic Surgery, Keelung Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, National Taiwan Ocean University, Keelung, Taiwan
    • ,
  • Jing-Duan Huang

      Affiliations

    • Institute of Marine Biology, National Taiwan Ocean University, Keelung, Taiwan

Accepted 8 December 2008.

Article Outline

Summary 

Objective

Estrogen deficiency results in postmenopausal osteoporosis by increasing the rate of bone loss. The mechanism responsible for the effects of estrogen on osteoclasts is still unclear.

Materials and Methods

The potential of mononuclear cells from cord blood or bone marrow to differentiate into mature osteoclasts when co-cultured with human osteoblast cells was investigated. The effects of estrogen on osteoclastogenesis and osteoclast activity were also examined.

Results

Macrophage markers CD11b and CD14 were downregulated and vitronectin receptor was upregulated during 28 days' co-culture of mononuclear cells and human osteoblasts. Long-term co-culture resulted in the formation of numerous large tartrate-resistant acid phosphatase-positive multinucleated cells capable of resorption of bone slices. After incubation for 28 days, the addition of 17β-estradiol caused a significant decrease in the expression of vitronectin receptor and tartrate-resistant acid phosphatase-positive multinucleated cells in cultures derived from both bone marrow and cord blood. A significant decrease in bone resorption was also noted in the presence of estrogen.

Conclusion

Estrogen not only suppresses osteoclastogenesis but also inhibits the activity of osteoclasts.

Key Words:  bone marrow , cord blood , osteoblast , postmenopausal osteoporosis

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Hughes DE , Dai A , Tiffee JC , Li HH , Mundy GR , Boyce BF . Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β . Nat Med . 1996;2:1132–1136
  2. Mano H , Yuasa T , Kameda T , et al.   Mammalian mature osteoclasts as estrogen target cells . Biochem Biophys Res Commun . 1996;223:637–642
  3. Tobias JH , Chambers TJ . The effect of sex hormones on bone resorption by rat osteoclasts . Acta Endocrinol (Copenh) . 1991;124:121–127
  4. Horowitz MC . Cytokines and estrogen in bone: anti-osteoporotic effects . Science . 1993;260:626–627
  5. Manolagas SC , Jilka RL . Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis . N Engl J Med . 1995;332:305–311
  6. Pacifici R . Estrogen, cytokines, and pathogenesis of post-menopausal osteoporosis . J Bone Miner Res . 1996;8:1043–1051
  7. Turner RT , Riggs BL , Spelsberg TC . Skeletal effects of estrogen . Endocr Rev . 1994;15:275–300
  8. Roodman GD . Cell biology of the osteoclast . Exp Hematol . 1999;27:1229–1241
  9. Kimble RB , Bain SD , Pacifici R . The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice . J Bone Miner Res . 1997;12:935–941
  10. Cosman F , Lindsay R . Selective estrogen receptor modulators: clinical spectrum . Endocr Rev . 1999;20:418–434
  11. Chen FP , Lee N , Wang KC , Soong YK , Huan KE . Effect of estrogen and 1α,25(OH)2-vitamin D3 on the activity and growth of human primary osteoblast-like cells in vitro . Fertil Steril . 2002;77:1038–1043
  12. Stanley ER , Guilbert LJ , Tushinski RJ , Bartelmez SH . CSF-1–a mononuclear phagocyte lineage-specific hemopoietic growth factor . J Cell Biochem . 1983;21:151–159
  13. Takeshita S , Kaji K , Kudo A . Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts . J Bone Miner Res . 2000;15:1477–1488
  14. Kawamoto S , Ejiri S , Nagaoka E , Ozawa H . Effects of oestrogen deficiency on osteoclastogenesis in the rat periodontium . Arch Oral Biol . 2002;47:67–73
  15. Ramalho AC, Couttet P, Baudoin C, Morieux C, Graulet AM, de Vernejoul MC, et al. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures . Eur Cytokine Netw . 2002;13:39–45
  16. Shevde NK , Bendixen AC , Dienger KM , Pike JW . Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression . Proc Natl Acad Sci U S A . 2000;14:7829–7834
  17. Srivastava S , Toraldo G , Weitzmann MN , Cenci S , Ross FP , Pacifici R . Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-κB ligand (RANKL)-induced JNK activation . J Biol Chem . 2001;276:8836–8840
  18. Sarma U , Edwards M , Motoyoshi K , Flanagan AM . Inhibition of bone resorption by 17β-estradiol in human bone marrow cultures . J Cell Physiol . 1998;175:99–108

PII: S1028-4559(09)60323-5

doi:10.1016/S1028-4559(09)60323-5

Taiwanese Journal of Obstetrics and Gynecology
Volume 48, Issue 4 , Pages 350-355, December 2009

Article Tools